참고문헌
-
Amarante-Mendes, G., McGahon, A, Nishioka, W, Afar, D., Witte, O. and Green, D. (1998) Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-
$x_{L}$ . Oncogene 16, 1383-1390. https://doi.org/10.1038/sj.onc.1201664 - Akao, Y., Mizoguchi, H., Kojima, S., Naoe, T., Ohishi, N. and Yagi, K (1998) Arsenic induces apoptosis in B-cell leukemic cell lines in vitro: activation of caspases and down-regulation of Bcl-2 protein. Br. J. Haematol. 102, 1055-1060. https://doi.org/10.1046/j.1365-2141.1998.00869.x
-
Bazarbachi, A, EI-Sabban, M. E., Nasr, R., Quignon, E, Awaraji, C., Kersual, J., Dianoux, L., Zennati, Y., Haidar, J. H., Hennine, O. and de The, H. (1999) Arsenic trioxide and interferon-
$\alpha$ synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transfonned cells. Blood 93, 278-283. - Bradford, M. (1976) A rapid and sensitive method for the quantitation of micrograrn quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. https://doi.org/10.1016/0003-2697(76)90527-3
-
Butterfield, L., Storey, B., Maas, L. and Heasley, L. E. (1997) C-Jun
$NH_{2}$ -tenninal kinase regulation of the apoptotis response ofsmall cell lung cancer cells to ultraviolet radiation. J. Biol. Chem. 272, 10110-10116. https://doi.org/10.1074/jbc.272.15.10110 -
Chen. G. Q., Zhu, J. and Shi, X. G. (1996) In vitro studies on cellular and molecular mechanism arsenic trioxide in the treatment of acute promyelocytic leukemia:
$As_{2}$ $O_{3}$ induces$NB_{4}$ cell apoptosis with down regulation of bcl-2 expression and modulation of PML-RAR$\alpha$ proteins. Blood 88, 1052-1061. -
Chen, G. Q., Shi, X. G., Tang, W, Xiong, S. M., Zhu, J., Cai, X., Han, Z. G., Ni, J. H., Shi, G. Y., Jia, P. M., Liu, M. M., He, K L., Niu, c., Ma, J., Zhang, P., Zhang, T. D., Paul, P., Naoe, T., Kitamura, K, Miller, W, Waxman, S., Wang, Z. Y., de The, H., Chen, S. J. and Chen, Z. (1997) Use of arsenic trioxide (
$As_{2}O_{3}$ ) in the treatment of acute promyelocytic leukemia (APL): I.$As_{2}O_{3}$ Exerts dose-dependent dual effects on APL cells. Blood 89, 3345-3353. - Eastman, A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin. Cancer BioI. 6, 45-52. https://doi.org/10.1006/scbi.1995.0006
- Graves, J. D., Draves, K E., Craxton, A, Saklatvala, J., Krebs, E. G. and Clark, E. A (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mlgM-induced apoptosis of human B Iymphocytes. Proc. Natl. Acad. Sci. USA 93, 13814-l3818. https://doi.org/10.1073/pnas.93.24.13814
-
lwama, K, Nakajo, S., Aiuchi, T. and Nakaya, K (2001) Apoptosis induced by arsenic trioxide in leukemia U937 cells is dependent on activation of p38, inactivation of ERK and the
$CA^{2+}$ -dependent production of superoxide. Int. J. Cancer 92, 518-526. https://doi.org/10.1002/ijc.1220 - Juo, P., Kuo, C. J., Reynolds, S. E., Konz, R. E, Raingeaud, J., Davis, R. J., Biemann, H. P. and Blenis, J. (1997) Fas activation of the p38 mitogen-activated protein kinase signaling pathway requires ICE/CED-3 family proteases. Mol. Cell Biol. 17, 24-35. https://doi.org/10.1128/MCB.17.1.24
- Kawasaki, H., Moriguchi, T. and Matsuda, S. (1996) Ras-dependent and Ras-independent pathway in the stress-activated-protein- kinase cascade. Eur. J. Biochem. 241, 315-321. https://doi.org/10.1111/j.1432-1033.1996.00315.x
- Kirn, H. H., Kim, H. M., Kwack, K B., Kim, S. Wand Lee, Z. H. (2001) Osteoclast differentiation factor engages the PI 3- kinase, p38, and ERK pathways for avian osteoclast differentiation. J. Biochem. Mol. Biol. 34,421-427.
- Kim, S. S., Kim, Y. S., Jung, Y. W, Choi, H. I., Shim, M. J. and Kim, T. U. (1999) Taxol-induced apoptosis and nuclear translocation of mitogen-activated protein (MAP) kinase in HeLa cells. J. Biochem. Mol. Biol. 32, 379-384.
- Lee, N. K, Kim, H. J., Yang, S. J., Kim, Y. S .. Choi, H. I., Shim, M. J., Awh, O. D. and Kim, T. U. (2001) The anticancer mechanism of taxol-diethylenetriamine pentaacetate conjugate in HT29 human colorectal cancer cells. J. Biochem. Mol. Biol. 34, 237-243.
- Lim, C. P., Jain, N. and Cao, X. (1998) Stress-induced immediately-early gene, egr-1, involves activation of p38/JNK1. Oncogene 16, 2915-2916. https://doi.org/10.1038/sj.onc.1201834
- Lu, M., Levin, J., Sulpice, E., Sequeira-Le, Grand, A, Alemany, M., Caen, J. P. and Han, Z. C. (1999) Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines. Exp Hematol. 27, 845-852. https://doi.org/10.1016/S0301-472X(99)00014-4
- Marshall, C. J. (1995) Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185. https://doi.org/10.1016/0092-8674(95)90401-8
- Molnar, A, Theodoras, A. M., Zon, L. I. and Kyriakis, J. M. (1997) Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cyele progression at G1/S through a mechanism requiring p38/ RK J. Biol. Chem.20, 13229-13235.
- Mu, Z. M., Chin, K V., Liu, J. W, Lozano, G. and Chang, K S. ( 1994) PML. A growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell BioI. 14, 6858-6867. https://doi.org/10.1128/MCB.14.10.6858
- Perkins, C., Kim, N. K, Fang, G. and Bhalla, K (2000) Arsenic induces apoptosis of multi-drug resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2 or Bcl-xL. Blood 95, 1014-1022.
- Rousselot, P., Labaume, S., Marolleau, J. P., Larghero, J., Noguera, M. H., Brouet, J. C. and Fennand, J. P. (1999) Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients. Cancer Res. 59, 1041- 1048.
-
Shao, W., Fenelli, M. and Ferrara, M. (1998) Arsenic trioxide as a inducer of apoptosis and loss of PML-RAR
$\alpha$ protein in acute promyelocytic leukemia cells. J. Natl. Cancer Inst. 90, 124-133. https://doi.org/10.1093/jnci/90.2.124 -
Shen, Z. X., Chen, G. Q., Ni, J. H., Li, X. S., Xiong, S. M., Qiu, Q. Y., Zhu, J., Tang, W., Sun, G. L., Yang, K Q., Chen, Y., Zhou, L., Fang, Z. w., Wang, Y. T., Ma, J., Zhang, T. D., Chen, S. J., Chen, Z. and Wang, Z. Y. (1997) Use of arsenic trioxide (
$As_{2}O_{3}$ ) in the treatment of acute promyelocytic leukemia (APL):$\Pi$ . Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89, 3354-3360. - So, E. Y., Jang, J. Y. and Lee, C. E. (2001) Cross-talk between STAT6 and Ras/MAPK pathway for the IL-4-mediate. J. Biochem. Mol. Biol. 34, 578-583.
- Soignet, S. L., Maslak, P., Wang, Z. G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A, Gabrilove, J. L., Scheinberg, D. A, Pandolfi, P. P. and Warrell, R P. (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339, 1341- 1348. https://doi.org/10.1056/NEJM199811053391901
- Wang, Z. G., Rivi, R, Delva, L., Konig, A, Scheinberg, D. A, Gambacorti, P. C., Gabrilove, J. L., Warrell, R P. and Pandolfi, P. P. (1998) Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARa independent manner. Blood 92, 1497-1504.
- Witte, O. N. (1999) Role of the BCR-ABL oncogene in human leukemia. Cancer Res. 53, 485-489.
- Xia, Z., Dickens, M, Raingeaud, J., Davis, R. J. and Greenberg, M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331. https://doi.org/10.1126/science.270.5240.1326
- Zhang, W., Ohnishi, K, Shigeno, K, Fujisawa, S., Naito, K, Nakamura, S., Takeshita, K, Takeshita, A and Ohno, R. (1998) The induction of apoptosis and cell cycle arrest by arsenic trioxide at clinically achievable concentrations. J. Natl. Cancer Inst. 91, 772-778.
피인용 문헌
- Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity 2009, https://doi.org/10.1002/em.20505
- Arsenic trioxide induces cardiac fibroblast apoptosis in vitro and in vivo by up-regulating TGF-β1 expression vol.219, pp.3, 2013, https://doi.org/10.1016/j.toxlet.2013.03.024
- PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: Involvement of p38 mitogen activated protein kinase vol.198, pp.2, 2004, https://doi.org/10.1002/jcp.10728
- Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms vol.65, pp.5, 2011, https://doi.org/10.1016/j.biopha.2011.04.016
- Syk is a novel target of arsenic trioxide (ATO) and is involved in the toxic effect of ATO in human neutrophils vol.24, pp.3, 2010, https://doi.org/10.1016/j.tiv.2009.11.011
- Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cδ vol.21, pp.7, 2007, https://doi.org/10.1038/sj.leu.2404735
- Arsenic-induced alteration in intracellular calcium homeostasis induces head kidney macrophage apoptosis involving the activation of calpain-2 and ERK in Clarias batrachus vol.256, pp.1, 2011, https://doi.org/10.1016/j.taap.2011.07.007
- Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation vol.82, pp.11, 2011, https://doi.org/10.1016/j.bcp.2011.08.017
- Morin inhibits 12-O-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression vol.69, pp.11, 2005, https://doi.org/10.1016/j.bcp.2005.03.008
- Resveratrol protects against arsenic trioxide-induced oxidative damage through maintenance of glutathione homeostasis and inhibition of apoptotic progression vol.56, pp.3, 2015, https://doi.org/10.1002/em.21919
- Arsenic trioxide: An anti cancer missile with multiple warheads vol.10, pp.3, 2005, https://doi.org/10.1080/10245330500067090
- Caspase-mediated Cell Death in Hematological Malignancies: Theoretical Considerations, Methods of Assessment, and Clinical Implications vol.44, pp.7, 2003, https://doi.org/10.1080/1042819031000077007
- Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer vol.54, pp.1, 2004, https://doi.org/10.1007/s00280-004-0770-9
- The two opposite facets of arsenic: toxic and anticancer drug pp.2013, 2013, https://doi.org/10.5339/jlghs.2013.1
- Knockdown of Acyl-CoA thioesterase 9 gene expression by siRNA confers resistance to arsenite in HEK293 cells vol.2, pp.6, 2015, https://doi.org/10.2131/fts.2.245
- Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside vol.45, pp.12, 2004, https://doi.org/10.1080/10428190412331272686
- Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK) vol.220, pp.3, 2007, https://doi.org/10.1016/j.taap.2007.01.022
- The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis vol.15, pp.1, 2015, https://doi.org/10.1186/s12935-015-0158-4
- Inhibition of mitogen-activated protein kinase kinase enhances apoptosis induced by arsenic trioxide in human breast cancer MCF-7 cells vol.32, pp.12, 2005, https://doi.org/10.1111/j.1440-1681.2005.04302.x
- Proliferation-Attenuating and Apoptosis-Inducing Effects of Tryptanthrin on Human Chronic Myeloid Leukemia K562 Cell Line in Vitro vol.12, pp.12, 2011, https://doi.org/10.3390/ijms12063831
- Curcumin Derivatives Inhibit the Formation of Jun-Fos-DNA Complex Independently of their Conserved Cysteine Residues vol.38, pp.4, 2005, https://doi.org/10.5483/BMBRep.2005.38.4.474
- The role of Akt on Arsenic trioxide suppression of 3T3-L1 preadipocyte differentiation vol.15, pp.5, 2005, https://doi.org/10.1038/sj.cr.7290305
- Therapeutic Effect of Arsenicum album on Leukocytes vol.13, pp.12, 2012, https://doi.org/10.3390/ijms13033979
- Regulating expressions of cyclin D1, pRb, and anti-cancer effects of deguelin on human Burkitt's lymphoma Daudi cells in vitro1 vol.26, pp.7, 2005, https://doi.org/10.1111/j.1745-7254.2005.00104.x
- SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide vol.1833, pp.10, 2013, https://doi.org/10.1016/j.bbamcr.2013.06.003
- Reliable Predictors of Arsenic Occurrence in the Southern Gulf Coast Aquifer of Texas vol.8, pp.5, 2018, https://doi.org/10.3390/geosciences8050155